BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma. (Q36346020)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma. |
scientific article |
Statements
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma (English)
Kevin B Kim
Jeffrey A Sosman
John P Fruehauf
Gerald P Linette
Svetomir N Markovic
David F McDermott
Jeffrey S Weber
Hoa Nguyen
Peter Cheverton
Amy C Peterson
William E Carson
Steven J O'Day
28 November 2011
1 reference
1 reference
1 reference
1 reference
1 reference